A genetic screen identifies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway
Morvarid Mohseni(Bristol-Myers Squibb (United States)), Fernando D. Camargo(Harvard Stem Cell Institute), Carla F. Kim(Harvard Stem Cell Institute), Jeffrey D. Goldsmith(Beth Israel Deaconess Medical Center), Jianlong Sun(ShanghaiTech University), Owen Samson(Cancer Research UK Scotland Institute), Victor L. Fox(Boston Children's Hospital), Marsha L. Frazier(The University of Texas MD Anderson Cancer Center), Chongjuan Wei(Affiliated Hospital of Guilin Medical College), Kwok‐Kin Wong(NYU Langone Health), Stephen J. Curtis(Albion Centre), Allison N. Lau(Pfizer (United States))
Cited by 296
Related Papers
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
|Nature Medicine|2008|1.3k
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
|Cell|2009|1k
High-throughput oncogene mutation profiling in human cancer
|Nature Genetics|2007|996
Clonal dynamics of native haematopoiesis
|Nature|2014|838